ID1.AU Identifai Genetics Limited

Healthcare Diagnostics & Research Australian Securities Exchange
0.3500 AUD
Close of Nov 1, 2026
0.2150 0.5600
Market cap
AUD 67.2M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is ID1.AU undervalued?

Graham number

The Graham number of Identifai Genetics Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Identifai Genetics Limited fundamental analysis

No fundamental analysis for Identifai Genetics Limited yet.

Identifai Genetics Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Identifai Genetics Limited

Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 202…

Full company profile